Bioscience Animal Health PCLBKK:BIS +0.98%81 EV-to-FCF is 1.67 as of Jul. 13, 2026, which is 1% above its 10-year median of 1.65. GuruFocus rates BKK:BIS with a GF Score™ of 81/100 and a GF Value™ of ฿2.87 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,187 Consumer Packaged Goods companies, Bioscience Animal Health PCL ranks better than 95.62% on this metric.
The historical rank and industry rank for Bioscience Animal Health PCL's EV-to-FCF or its related term are showing as below:
BKK:BIS'
s EV-to-FCF Range Over the Past 10 Years
Min: -58.82 Med: 1.65 Max: 3528.98
Current: 1.67
During the past 9 years, the highest EV-to-FCF of Bioscience Animal Health PCL was 3528.98. The lowest was -58.82. And the median was 1.65.
BKK:BIS's EV-to-FCF is ranked better than 95.62% of 1187
companies
in the Consumer Packaged Goods industry
Industry Median: 15.72
vs BKK:BIS: 1.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bioscience Animal Health PCL (BKK:BIS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bioscience Animal Health PCL's PE Ratio (TTM) for today is calculated as:
Bioscience Animal Health PCL's share price for today is ฿2.06.
Bioscience Animal Health PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bioscience Animal Health PCL EV-to-FCF Related Terms
Bioscience Animal Health PCL EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioscience Animal Health PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioscience Animal Health PCL EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bioscience Animal Health PCL's EV-to-FCF falls into.
Bioscience Animal Health PCL's current Enterprise Value is ฿370 Mil.
Bioscience Animal Health PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿221 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioscience Animal Health PCL (BKK:BIS) has a EV-to-FCF of 1.67 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bioscience Animal Health PCL and its competitors. This is near median its historical median of 1.65. According to the industry distribution chart, Bioscience Animal Health PCL ranks #52 out of 1187 companies in the Consumer Packaged Goods industry, placing it in the top 4.4%.
Is Bioscience Animal Health PCL's EV-to-FCF too high?
Bioscience Animal Health PCL's current EV-to-FCF of 1.67 is near median its 10-year median of 1.65. The Consumer Packaged Goods industry median EV-to-FCF is 15.72. Bioscience Animal Health PCL's value of 1.67 is 89.4% below this industry median. Based on the distribution chart, Bioscience Animal Health PCL ranks #52 out of 1187 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Bioscience Animal Health PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioscience Animal Health PCL ranks #52 out of 1187 companies for EV-to-FCF. This places Bioscience Animal Health PCL in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 15.72. Bioscience Animal Health PCL's value of 1.67 is 89.4% below this benchmark. While the company's 10-year median is 1.65 vs. the industry median of 15.72, Bioscience Animal Health PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.72, based on 1,187 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioscience Animal Health PCL's current EV-to-FCF of 1.67 is 89.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bioscience Animal Health PCL and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioscience Animal Health PCL's current EV-to-FCF is 1.67, which is near median its own 10-year median of 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.87, compared to a current price of ฿2.06 — trading 28.2% below its estimated fair value. The current EV-to-FCF is 1.67, which is near median its 10-year median of 1.65 and 89.4% below the Consumer Packaged Goods industry median of 15.72. Bioscience Animal Health PCL's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current EV-to-FCF is 1.67 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.06 is trading 28.2% below its estimated GF Value™ of ฿2.87.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
EV-to-FCF: 1.67 (near median its 10-year median of 1.65)
GF Value™: ฿2.87 vs. price of ฿2.06 (28.2% below fair value)
Industry Position: 89.4% below the Consumer Packaged Goods median (#52 of 1187)
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
81GF Score
Get the complete analysis for BKK:BIS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
